• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Telemedicine catches ROP, NEI study finds

Article

A National Eye Institute (NEI) study found that telemedicine can effectively screen for retinopathy of prematurity (ROP) and could potentially ease the strain on hospitals with limited access to ophthalmologists.

A National Eye Institute (NEI) studyfound that telemedicine can effectively screen for retinopathy of prematurity (ROP) and could potentially ease the strain on hospitals with limited access to ophthalmologists.

Second Sight, Kellog Eye Center finding early success with artificial retina

The study evaluated telemedicine for ROP screening during the care of 1,257 premature babies. Every nine days or so, each infant was screened by an ophthalmologist, who assessed whether referral treatment was warranted. Either immediately before or after that exam, a staff member took photos of babies’ eyes, which were sent to a secure server at the University of Oklahoma, Oklahoma City for evaluation by staff who were trained to recognize signs of severe ROP. The staff then made recommendations on whether the infant should be referred to an eyecare professional for further treatment.

The non-physician image readers in Oklahoma City correctly identified 90 percent of the infants that needed a referral based on examination by an ophthalmologist, and they correctly identified 87 percent of the infants who did not need a referral. The examining ophthalmologists documented 244 infants with ROP who needed a referral on exam, 162 of whom were treated. Of these, non-physician image readers identified ROP that warranted a referral in all but three infants (98 percent).

According to NEI, some signs of ROP appear in about half of infants born at or before 30 weeks, but only five to eight percent of those cases become severe enough to require treatment. 

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.